Speaking earlier today during a panel at the World Economic Forum in Switzerland, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), announced plans to establish a new Tuberculosis (TB) Vaccine Accelerator Council.
The Council will facilitate the licensing and use of effective novel TB vaccines catalyzing high-level alignment between funders, global agencies, governments, and end users in identifying and overcoming barriers to TB vaccine development.
TB Vaccine Accelerator Council Announced
Detecting Flu Viruses at Airports
Ginkgo Bioworks today announced that they had expanded their support for the U.S. Centers for Disease Control and Prevention's (CDC) Traveler-based Genomic Surveillance (TGS) program to include a study monitoring influenza viruses.
Traveler-based pathogen monitoring represents a novel approach to influenza surveillance, complementing CDC's ongoing efforts by providing early insights into global trends in influenza virus evolution.
Detecting Flu Viruses at Airports
Ginkgo Bioworks today announced that they had expanded their support for the U.S. Centers for Disease Control and Prevention's (CDC) Traveler-based Genomic Surveillance (TGS) program to include a study monitoring influenza viruses.
Traveler-based pathogen monitoring represents a novel approach to influenza surveillance, complementing CDC's ongoing efforts by providing early insights into global trends in influenza virus evolution.
Convalescent COVID-19 Plasma Beneficial for Immunocompromised
Reduction seen in mortality with COVID-19 convalescent plasma transfusion in randomized clinical trials, matched cohort studies